VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
INTTinTEST Corporation
$16.23$203M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksINTTFinancials

inTEST Corporation (INTT) Financials

30Y historyFree accessUpdated daily

Operating margins remain highly volatile, swinging from a positive 5.7% in 2024Q4 to a negative 10.8% in 2025Q1, reflecting the firm's high fixed-cost structure.

INTT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue121.07M113.83M130.69M123.3M116.83M84.88M53.82M60.66M78.56M66.8M40.23M38.89M41.8M39.43M43.38M47.27M46.2M23.5M38.79M48.7M62.35M53.36M71.21M48.03M47.13M51.63M87.65M34.5M19.1M20.7M18.6M
Revenue Growth %-5.04%-12.9%5.99%5.54%37.64%57.7%-11.27%-22.79%17.61%66.06%3.44%-6.96%6.01%-9.11%-8.23%2.3%96.62%-39.42%-20.36%-21.88%16.84%-25.07%48.27%1.91%-8.72%-41.1%154.06%80.63%-7.73%11.29%-
Cost of Goods Sold67.8M64.91M75.27M66.32M63.39M43.65M29.72M31.43M39.16M32.11M19.85M20.19M21.33M20.41M24.32M24.37M24.06M15.69M25M29.92M35.95M33.63M42.42M29.18M28.89M38.92M46.02M14.7M7.9M7.6M6.7M
COGS % of Revenue-57.02%57.59%53.79%54.26%51.43%55.22%51.82%49.85%48.07%49.34%51.92%51.04%51.77%56.06%51.57%52.07%66.75%64.46%61.44%57.67%63.03%59.57%60.75%61.3%75.38%52.5%42.61%41.36%36.71%36.02%
Gross Profit53.27M48.92M55.42M56.98M53.44M41.22M24.1M29.23M39.4M34.69M20.38M18.7M20.46M19.02M19.06M22.89M22.14M7.81M13.79M18.78M26.39M19.73M28.79M18.85M18.24M12.71M41.63M19.8M11.2M13.1M11.9M
Gross Margin %44%42.98%42.41%46.21%45.74%48.57%44.78%48.18%50.15%51.93%50.66%48.08%48.96%48.23%43.94%48.43%47.93%33.25%35.54%38.56%42.33%36.97%40.43%39.25%38.7%24.62%47.5%57.39%58.64%63.29%63.98%
Gross Profit Growth %--11.73%-2.73%6.62%29.63%71.03%-17.52%-25.83%13.58%70.23%8.98%-8.62%7.61%-0.23%-16.75%3.38%183.44%-43.32%-26.6%-28.84%33.8%-31.48%52.74%3.34%43.49%-69.47%110.25%76.79%-14.5%10.08%-
Operating Expenses53.16M52.65M52.03M46.54M42.72M32.77M25.32M26.68M27.32M24.1M16.23M16.14M15.55M15.05M15.75M15.31M14.79M12.2M21M25.63M22.85M11.92M26.5M22.68M20.05M27.4M27.63M13.5M8.6M6.9M6.3M
OpEx % of Revenue-46.25%39.81%37.74%36.57%38.6%47.04%43.98%34.77%36.08%40.35%41.49%37.19%38.18%36.31%32.4%32.02%51.9%54.14%52.63%36.65%22.34%37.21%47.23%42.53%53.07%31.53%39.13%45.03%33.33%33.87%
Selling, General & Admin38.99M39.01M43.48M38.92M35.19M26.95M18.97M21.71M22.41M19.8M12.57M12.2M11.97M11.37M11.86M12.07M11.75M9.78M15.94M16.73M17.41M16.77M19.52M16.28M14.38M16.66M18.98M9.4M6.2M5M4.3M
SG&A % of Revenue-34.27%33.27%31.57%30.12%31.75%35.24%35.79%28.53%29.64%31.25%31.37%28.63%28.84%27.33%25.55%25.43%41.61%41.09%34.35%27.93%31.44%27.42%33.9%30.51%32.26%21.66%27.25%32.46%24.15%23.12%
Research & Development9.58M9.44M8.55M7.62M7.53M5.53M5.07M4.96M4.91M4.3M3.66M3.94M3.58M3.68M3.9M3.24M3.04M2.42M5.06M5.52M5.44M5.94M6.97M6.4M5.67M6.13M6.58M3.2M1.9M1.7M1.9M
R&D % of Revenue-8.29%6.54%6.18%6.44%6.52%9.42%8.18%6.25%6.44%9.1%10.12%8.57%9.34%8.98%6.85%6.59%10.29%13.05%11.33%8.72%11.13%9.79%13.33%12.03%11.88%7.5%9.28%9.95%8.21%10.22%
Other Operating Expenses3.96M4.2M000286K1.28M55K-137K227K61K21K-7K46K57K72K0003.38M0-10.8M0004.61M2.07M900K500K200K100K
Operating Income854K-3.73M3.39M10.44M10.72M8.46M-1.22M-644K5.18M3.61M4.15M2.56M4.92M3.96M3M7.58M7.35M-5.05M-9.44M-6.85M3.52M-3.56M1.67M-3.83M-1.81M-14.69M14M6.3M2.6M6.2M5.6M
Operating Margin %0.71%-3.27%2.6%8.47%9.18%9.97%-2.26%-1.06%6.59%5.41%10.31%6.59%11.76%10.05%6.91%16.03%15.91%-21.47%-24.34%-14.07%5.65%-6.68%2.34%-7.98%-3.83%-28.45%15.97%18.26%13.61%29.95%30.11%
Operating Income Growth %--209.75%-67.49%-2.63%26.74%795.07%-88.98%-112.43%43.45%-12.9%61.83%-47.88%24.08%32.24%-60.46%3.1%245.66%46.55%-37.75%-294.69%198.82%-313.81%143.45%-112.29%87.71%-204.95%122.16%142.31%-58.06%10.71%-
EBITDA6.12M3.07M8.84M15.12M15.46M11.6M1.96M2.55M7.05M5.39M4.75M3.32M5.79M4.81M3.93M7.97M7.75M-4.54M-8.37M-5.16M5.32M-1.69M3.77M-1.81M111K-12.51M16.07M7.2M3.1M6.4M5.7M
EBITDA Margin %5.05%2.7%6.76%12.26%13.23%13.67%3.64%4.2%8.97%8.07%11.8%8.53%13.87%12.2%9.06%16.87%16.76%-19.34%-21.57%-10.6%8.53%-3.17%5.3%-3.76%0.24%-24.23%18.33%20.87%16.23%30.92%30.65%
EBITDA Growth %3.1%-65.25%-41.56%-2.15%33.19%492.95%-23.22%-63.85%30.82%13.59%43.09%-42.78%20.5%22.4%-50.71%2.93%270.41%45.68%-62.09%-197.07%414.86%-144.78%308.74%-1727.93%100.89%-177.83%123.19%132.26%-51.56%12.28%-
D&A (Non-Cash Add-back)5.26M6.8M5.44M4.68M4.73M3.15M3.17M3.19M1.87M1.78M599K754K879K847K933K394K395K501K1.07M1.69M1.8M1.87M2.11M2.03M1.92M2.18M2.07M900K500K200K100K
EBIT819K-2.77M4.3M11.73M10.78M8.49M68K2.79M12.08M10.59M4.15M2.56M4.92M3.96M3.31M7.58M7.46M-4.82M-9.06M-6.85M3.54M-2.94M2.45M-3.83M-1.81M-14.69M14M7.33M2.08M6.2M5.6M
Net Interest Income-378K-450K-846K-679K-635K-89K0000000009K-52K-28K276K418K350K174K76K48K70K182K462K0000
Interest Income00000000000000013K12K44K297K420K355K189K89K67K110K213K493K0000
Interest Expense378K450K846K679K635K89K00137K0007K004K64K72K21K2K5K15K13K19K40K31K31K0000
Other Income/Expense-310K503K60K609K-576K-57K-14K55K-137K227K61K21K-7K46K57K81K50K151K360K392K470K124K-77K224K143K551K-2.42M1.26M-361K200K-100K
Pretax Income544K-3.22M3.45M11.05M10.14M8.4M-1.23M2.6M5.04M3.84M4.21M2.58M4.91M4.01M3.05M7.66M7.4M-4.89M-9.08M-6.46M3.99M-3.38M1.67M-3.61M-1.66M-14.14M11.58M6.7M3M6.4M5.5M
Pretax Margin %0.45%-2.83%2.64%8.96%8.68%9.9%-2.29%4.29%6.42%5.75%10.46%6.64%11.75%10.17%7.04%16.2%16.02%-20.83%-23.41%-13.27%6.4%-6.34%2.34%-7.52%-3.53%-27.38%13.21%19.42%15.71%30.92%29.57%
Income Tax-47K-695K563K1.71M1.68M1.12M-336K282K2.01M2.86M1.55M722K1.47M931K897K-2.2M148K-52K53K278K1.12M236K398K1.84M-1.38M-2.81M5.2M2.6M1.1M2.1M900K
Effective Tax Rate %-8.64%21.57%16.3%15.44%16.6%13.32%27.29%10.83%39.78%74.6%36.82%27.95%29.94%23.23%29.38%-28.78%2%1.06%-0.58%-4.3%28.05%-6.97%23.86%-51%82.98%19.87%44.91%38.81%36.67%32.81%16.36%
Net Income591K-2.53M2.89M9.34M8.46M7.28M-895K2.32M3.04M975K2.66M1.86M3.44M3.08M2.16M9.86M7.25M-4.84M-9.13M-6.74M2.87M-3.62M1.27M-5.45M-283K-11.33M6.38M4.1M1.9M4.3M4.6M
Net Margin %0.49%-2.22%2.21%7.58%7.24%8.58%-1.66%3.83%3.87%1.46%6.61%4.79%8.23%7.8%4.97%20.87%15.7%-20.61%-23.54%-13.84%4.6%-6.78%1.78%-11.35%-0.6%-21.94%7.28%11.88%9.95%20.77%24.73%
Net Income Growth %691%-187.41%-69.05%10.41%16.17%913.74%-138.54%-23.54%211.49%-63.32%42.83%-45.89%11.76%42.72%-78.14%36%249.74%46.97%-35.52%-334.73%179.31%-385.04%123.3%-1826.15%97.5%-277.6%55.59%115.79%-55.81%-6.52%-
Net Income (Continuing)591K-2.53M2.89M9.34M8.46M7.28M-895K2.32M3.04M975K2.66M1.86M3.44M3.08M2.16M9.86M7.25M-4.84M-9.13M-6.74M2.87M-3.62M1.27M-5.45M-283K-11.33M6.38M6.13M1.06M4.3M4.6M
Discontinued Operations0000000000000000000000000000000
Minority Interest000000000000000000000000000000300K
EPS (Diluted)0.05-0.210.240.790.780.68-0.090.220.290.090.260.180.330.300.210.960.72-0.49-0.96-0.730.31-0.410.14-0.65-0.03-1.370.750.740.310.730.83
EPS Growth %513.64%-187.5%-69.62%1.28%14.71%878.92%-139.68%-24.14%222.22%-65.38%44.44%-45.45%10%42.86%-78.13%33.33%246.94%48.96%-31.51%-335.48%175.61%-392.86%121.54%-1846.11%97.56%-282.67%1.35%138.71%-57.53%-12.05%-
EPS (Basic)--0.210.240.820.790.70-0.090.220.290.090.260.180.330.300.210.970.72-0.49-0.96-0.730.32-0.410.15-0.65-0.03-1.370.780.760.310.740.83
Diluted Shares Outstanding12.42M12.2M12.24M11.78M10.86M10.73M10.26M10.39M10.38M10.34M10.33M10.49M10.47M10.42M10.35M10.29M10.14M9.98M9.47M9.21M9.19M8.81M8.8M8.33M8.47M8.28M8.47M8.29M6.19M5.09M5.54M
Basic Shares Outstanding12.25M12.2M12.15M11.46M10.67M10.46M10.26M10.37M10.35M10.28M10.31M10.47M10.43M10.36M10.27M10.15M10.02M9.98M9.47M9.21M9.05M8.81M8.48M8.33M8.32M8.28M8.2M8.08M6.17M5.07M5.54M
Dividend Payout Ratio--------------38.68%--------------127.91%71.74%

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Cyclical Revenue Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Cyclical Revenue Growth Patterns

As indicated by the provided quarterly data, inTEST experienced significant revenue volatility, ranging from a 39.9% expansion in 2024Q4 to a 17.2% contraction in 2025Q2, highlighting the company's sensitivity to the capital expenditure cycles inherent in the semiconductor manufacturing and testing equipment industry.

The revenue trajectory appears highly dependent on project-based demand, which lacks the smoothing effect of recurring software or service revenue. Investors should monitor whether the recent 27.2% growth in 2026Q1 represents a sustainable recovery or merely a temporary rebound from the trough observed in mid-2025.

Structural Margin Sensitivity Observed

Based on the reported financial statements, gross margins have fluctuated between 39.7% and 46.3%, suggesting that the company's specialized product mix provides some pricing power, yet remains vulnerable to the input cost pressures and manufacturing inefficiencies that typically accompany lower production volumes during cyclical downturns.

The inability to maintain consistent gross margins above the 45% threshold during periods of revenue contraction implies that fixed manufacturing costs weigh heavily on the bottom line. This suggests that the company may struggle to protect profitability without a more standardized product offering or improved operational scale.

Operating Leverage Exacerbates Downturns

According to the income statement data, the company's operating margin swung from a positive 5.7% in 2024Q4 to a negative 10.8% in 2025Q1, demonstrating that the firm's high fixed-cost structure significantly amplifies the impact of revenue declines on overall operating profitability.

The rapid transition into negative operating territory suggests that the current SG&A and R&D expense base is not sufficiently flexible to adjust to sudden drops in demand. This operating leverage warrants further investigation into whether management can implement more variable cost structures to mitigate future cyclical risks.

Earnings Quality Impacted by SBC

As reported in the financial filings, stock-based compensation remains a consistent line item, frequently exceeding $350,000 per quarter, which serves to dilute the quality of reported net income and complicates the assessment of true operational profitability during periods of negative earnings.

The presence of recurring stock-based compensation during quarters where the company reports net losses suggests a disconnect between executive compensation and short-term operational performance. Investors should monitor these non-cash expenses as they continue to impact the bottom line regardless of the company's current cyclical position.

Sustainability of Diversification Strategy

While management emphasizes diversification into life sciences and industrial markets, the data suggests that the company's financial performance remains tethered to semiconductor capital expenditure, raising concerns that the purported hedge against cyclicality may be less effective than the current investment narrative implies.

The persistent sensitivity to semiconductor-related revenue suggests that the diversification efforts have not yet reached the critical mass required to decouple the firm from its core industry. This raises the risk that the company may remain a high-beta play on semiconductor equipment spending rather than a stable industrial manufacturer.

INTT — Frequently Asked Questions

Quick answers to the most common questions about buying INTT stock.

What was inTEST Corporation's (INTT) revenue in 2025?

For fiscal year 2025, inTEST Corporation (INTT) reported total revenue of $113.8M. This represents a 512.0% increase compared to $18.6M in 1996.

Is inTEST Corporation (INTT) profitable?

inTEST Corporation (INTT) reported a net loss of $2.5M for the fiscal year ending 2025.

What is inTEST Corporation's operating profit margin?

inTEST Corporation (INTT) reported an operating income of $-3.7M, resulting in an operating profit margin of -3.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is inTEST Corporation's gross profit and gross margin?

inTEST Corporation (INTT) generated $48.9M in gross profit for the year, representing a gross profit margin of 43.0%. This demonstrates the company's core pricing power and production efficiency.